SET and colorectal carcinoma: The fact that SET overexpression only associates with relapse in those cases with stage-II disease could be due to the fact that stage III encompasses patients with more advanced disease, where the presence of this alteration could be a less relevant event in the effort to determine relapse than in those cases with stage-II CRC.